Biomarkers in seminal fluid indicate presence and severity of prostate cancer

the ONA take:

Research findings from a study conducted at University of Adelaide in South Australia could improve diagnosis and management of prostate cancer. These results demonstrate that the presence of certain molecules in seminal fluid is indicative of whether a man has cancer. In addition, the biomarker indicates the severity of the cancer. Prostate-specific antigen (PSA) tests are not an ideal test for the cancer. It is not highly specific for prostate cancer, and results over-diagnosis and over-treatment of prostate cancers that could have been safely left alone. The scientists discovered a small number of microRNAs in seminal samples from 60 men that are known to be increased when prostate cancer is present. The study showed that presence of some of these microRNAs were surprisingly accurate in detecting cancer.

Biomarkers in seminal fluid indicate presence and severity of prostate cancer
Biomarkers in seminal fluid indicate presence and severity of prostate cancer
Improved diagnosis and management of one of the most common cancers in men - prostate cancer - could result from research at the research at the University of Adelaide, which has discovered that seminal fluid (semen) contains biomarkers for the disease.
READ FULL ARTICLE From News Medical
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs